Related references
Note: Only part of the references are listed.Sarcopenia-The Impact on Physical Capacity of Liver Transplant Patients
Maciej Miarka et al.
LIFE-BASEL (2021)
Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes
Laura I. Coman et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma
Israa T. Ismail et al.
CANCERS (2021)
Acute-on-Chronic Liver Failure in Cirrhosis
Carmine Gambino et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review
Liliana Lykowska-Szuber et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Micro-Elimination: Updated Pathway to Global Elimination of Hepatitis C in Small Communities and Industrial Settings during the COVID 19 Pandemic
Anca Elena Butaru et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
Dimitrios A. Vrachatis et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
Stanislav Kotlyarov et al.
CELLS (2021)
Sarcopenia and Frailty in Liver Cirrhosis
Hiroki Nishikawa et al.
LIFE-BASEL (2021)
Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors
Yoshihisa Takahashi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Liver injury in COVID-19: clinical features and treatment management
Dongdong Yu et al.
VIROLOGY JOURNAL (2021)
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Joao V. S. Guerra et al.
NUTRIENTS (2021)
Predictive Value of Comorbid Conditions for COVID-19 Mortality
Iosif Marincu et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis
Beatrice Foglia et al.
CELLS (2021)
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
Donovan A. McGrowder et al.
DISEASES (2021)
Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic
Bianca Cerbu et al.
MEDICINA-LITHUANIA (2021)
Elimination of hepatitis C in Europe: can WHO targets be achieved?
M. Maticic et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature
Michal Kukla et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study
Pierpaolo Di Micco et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
Katrine D. Galsgaard
JOURNAL OF CLINICAL MEDICINE (2020)
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
Alessia Di Costanzo et al.
BIOMEDICINES (2020)
Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia
Neven Papic et al.
INFECTIOUS DISEASE REPORTS (2020)
Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
Abdurrahman Sahin et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Epidemiology of hepatitis C in Europe
Francesco Negro
DIGESTIVE AND LIVER DISEASE (2014)
Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management
Diego Garcia-Compean et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Immunohistochemical detection of HCV in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR
A Rullier et al.
MODERN PATHOLOGY (2001)